These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 16988520)

  • 1. "Nothing new": responses to the introduction of antiretroviral drugs in South Africa.
    Chopra M; Kendall C; Hill Z; Schaay N; Nkonki LL; Doherty TM
    AIDS; 2006 Oct; 20(15):1975-7. PubMed ID: 16988520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'My biggest fear was that people would reject me once they knew my status...': stigma as experienced by patients in an HIV/AIDS clinic in Johannesburg, South Africa.
    Gilbert L; Walker L
    Health Soc Care Community; 2010 Mar; 18(2):139-46. PubMed ID: 19708868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug interactions between psychoactive substances and antiretroviral therapy in individuals infected with human immunodeficiency and hepatitis viruses.
    Neuman MG; Monteiro M; Rehm J
    Subst Use Misuse; 2006; 41(10-12):1395-463. PubMed ID: 17002989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The social construction of ARVs in South Africa.
    Sember R
    Glob Public Health; 2008; 3 Suppl 2():58-75. PubMed ID: 19288353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continued correspondence 'Will ART rollout in Africa drive an epidemic of drug-resistant HIV?'.
    Hastings IM; Lalloo DG; Khoo SH
    AIDS; 2007 Jan; 21(2):258-9; author reply 259-60. PubMed ID: 17197825
    [No Abstract]   [Full Text] [Related]  

  • 6. The Brazilian experiment: HIV drugs for all.
    Flaer PJ; Younis MZ
    J Health Care Finance; 2009; 36(2):90-6. PubMed ID: 20499725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspectives on the pediatric HIV/AIDS pandemic: catalyzing access of children to care and treatment.
    Kline MW
    Pediatrics; 2006 Apr; 117(4):1388-93. PubMed ID: 16585337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Public-sector ART in the Free State Province, South Africa: community support as an important determinant of outcome.
    Wouters E; Van Damme W; Van Loon F; van Rensburg D; Meulemans H
    Soc Sci Med; 2009 Oct; 69(8):1177-85. PubMed ID: 19692165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for the scale-up of antiretroviral therapy in South Africa through health system optimization.
    Barker PM; McCannon CJ; Mehta N; Green C; Youngleson MS; Yarrow J; Bennett B; Berwick DM
    J Infect Dis; 2007 Dec; 196 Suppl 3():S457-63. PubMed ID: 18181694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in normal activities, job performance and symptom prevalence between patients not yet on antiretroviral therapy and patients initiating therapy in South Africa.
    Rosen S; Ketlhapile M; Sanne I; Desilva MB
    AIDS; 2008 Jul; 22 Suppl 1():S131-9. PubMed ID: 18664945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knowledge and acceptability of HAART among TB patients in Durban, South Africa.
    Gebrekristos HT; Lurie MN; Mthethwa N; Karim QA
    AIDS Care; 2005 Aug; 17(6):767-72. PubMed ID: 16036263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment perceptions and attitudes of older human immunodeficiency virus-infected adults.
    Wutoh AK; Brown CM; Dutta AP; Kumoji EK; Clarke-Tasker V; Xue Z
    Res Social Adm Pharm; 2005 Mar; 1(1):60-76. PubMed ID: 17138466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antiretroviral treatment for HIV infection. Where we are and where we are going?].
    Sierra-Madero JG; Franco-San-Sebastián D
    Rev Invest Clin; 2004; 56(2):222-31. PubMed ID: 15377075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "No one can ask me 'Why do you take that stuff?'": men's experiences of antiretroviral treatment in South Africa.
    Fitzgerald M; Collumbien M; Hosegood V
    AIDS Care; 2010 Mar; 22(3):355-60. PubMed ID: 20390516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of antiretroviral treatment in a South African program: a cohort study.
    Fairall LR; Bachmann MO; Louwagie GM; van Vuuren C; Chikobvu P; Steyn D; Staniland GH; Timmerman V; Msimanga M; Seebregts CJ; Boulle A; Nhiwatiwa R; Bateman ED; Zwarenstein MF; Chapman RD
    Arch Intern Med; 2008 Jan; 168(1):86-93. PubMed ID: 18195200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining prevention, treatment and care: lessons from South Africa.
    Achmat Z; Simcock J
    AIDS; 2007 Jul; 21 Suppl 4():S11-20. PubMed ID: 17620746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. German-Austrian recommendations for the antiretroviral therapy of HIV-infection (status May 2004).
    Salzberger B; Marcus U; Vielhaber B; Arasteh K; Gölz J; Brockmeyer NH; Rockstroh J
    Eur J Med Res; 2004 Nov; 9(11):491-504. PubMed ID: 15649858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral therapy for HIV prevention: many concerns and challenges, but are there ways forward in sub-Saharan Africa?
    Zachariah R; Harries AD; Philips M; Arnould L; Sabapathy K; O'Brien DP; Ferreyra C; Balkan S
    Trans R Soc Trop Med Hyg; 2010 Jun; 104(6):387-91. PubMed ID: 20116814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risks and benefits of using antiretroviral therapy in HIV-infected patients with chronic hepatitis B in developing regions.
    Soriano V; Rivas P; Nuñez M
    Clin Infect Dis; 2008 Dec; 47(11):1486-9. PubMed ID: 18937578
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiretroviral therapy adherence in children: outcomes from Africa.
    Reddi A; Leeper SC
    AIDS; 2008 Apr; 22(7):906-7. PubMed ID: 18427213
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.